Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01802515 · ClinicalTrials.gov registry record · NA
A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01802515 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 14 participants.
The verdict
NCT01802515, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The main goal of this study is to evaluate the safety and tolerability of 40 or 80 mg atomoxetine as a treatment for cocaine dependence. The Phase I studies summarized above support the safety of atomoxetine in combination with stimulants. As the next step, the investigators will evaluate the safety and tolerability of atomoxetine in a small clinical trial with cocaine users. If atomoxetine is found to be promising in this study and sufficiently powered, double-blind, placebo-controlled studies will be proposed.
Interventions
- DRUG Placebo
- DRUG Atomoxetine, low dose
- DRUG Atomoxetine, high dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01802515
The ClinicalTrials.gov registry entry for NCT01802515 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01802515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01802515 about?
NCT01802515 is a clinical study titled "A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment". The main goal of this study is to evaluate the safety and tolerability of 40 or 80 mg atomoxetine as a treatment for cocaine dependence. The Phase I studies summarized above support the safety of atomoxetine in combination with stimulants. As the next step, the investigators will evaluate the safety...
What is the current status of trial NCT01802515?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2012-12. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01802515?
The interventions under investigation include: Placebo (DRUG), Atomoxetine, low dose (DRUG), Atomoxetine, high dose (DRUG).
Who is sponsoring clinical trial NCT01802515?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.